| 标题 |
primary CD34+ derived mast cells provide an excellent platform to assess single agent and combination therapies for mastocytosis |
| 网址 | |
| DOI |
10.1182/blood-2025-7278
doi
|
| 其它 |
期刊:Blood 作者:Rushil Patel; Yongzhao Huang; Aisha M. Mergaert; Emer Clarke 出版日期:2025-11-03 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)